- Korea Institute of Toxicology (KITOX)

image of Korea Institute of Toxicology(KITOX)

Korea Institute of Toxicology(KITOX)

Safety assessment study of various substances such as chemical and biotechnology,
development of related technology, and industry-university research support

Korea Institute of Toxicology(KITOX) - provided in order to President, Establishment Date, Location, Contact, Homepage.
President Jung, Eun Joo
Establishment Date 2002.01.01
Location KITOX, 141, Gajeong-ro, Yuseong-gu, Daejeon
Contact 042-610-8250
Homepage www.kitox.re.kr

Key Functions

  • To research safety assessment and develop related technology
  • To research pharmacological evaluation and develop related technology
  • To research environment toxicity and develop risk assessment technology
  • To cooperate with government, the private sector, corporations, and organizations for R&D and provide and commission technical services
  • Cooperation and support of related SMEs for chemical and bio industries and technology commercialization
  • To train specialized human resources, construct and operate public infrastructure, and supprot related policy making

Recent Achievements

  • Korea’s first certified US FDA eligible non-clinical testing organization
    • Possible US new drug approval of Dong-A Pharmaceutical’s ‘Zydena’ executed by KIT
  • US FDA sale authorization of ‘Kynamro’ a new non-clinical drug of KIT
    • World’s second approval of nucleic acid antisense drug
  • Quasi-drug designation of humidifier fungicide by the cause investigation of lung disease through inhalation toxicity test
  • Contribution of medical support for under-developed countries through the national first success in the EMA new drug approval